Brief: Chimeric Therapeutics Says Appointment Of Rebecca Mcqualter As CEO
12/11/2024 01:13
Nov 12 (Reuters) - Chimeric Therapeutics CHM.AX :
* APPOINTMENT OF REBECCA MCQUALTER AS CEO
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial